United States · FDA National Drug Code directory

Tizanidine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
35356-662_22a584c3-8b07-40b4-b70f-8857c268cebc
Product NDC
35356-662
Form
TABLET
Composition / generic term
Tizanidine
Labeler
Quality Care Products, LLC
Marketing category
ANDA
Marketing start / end (source format)
20070206 / 20270331

Source-listed ingredients

  • TIZANIDINE HYDROCHLORIDE — 2 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (35356-662-30) · 35356-662-30
  • 60 TABLET in 1 BOTTLE (35356-662-60) · 35356-662-60
  • 90 TABLET in 1 BOTTLE (35356-662-90) · 35356-662-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →